Business Development and Collaborations

Your Partner in Ultrasensitive Detection

Jaden is actively seeking new partnerships to expand its existing commercial product portfolio, and research and development programs in the area of novel cell surface markers for clinical diagnostic applications. Jaden's core technology platform can be applied to a wide variety of simple, low cost ultrasensitive diagnostic tests for the research market, biopharmaceutical and pharmaceutical discovery and ultimately individual patient management. Jaden's technology can be adapted to companion diagnostics, for use in the selection of subjects most likely to respond to study drug or monitoring programs to evaluate subject's response to study drug. Our goal is to develop high quality, robust, and affordable assays sensitive enough to detect cancer and other diseases in a single drop of blood.

In addition, Jaden seeks qualified research laboratories interested in participating in our beta-site testing program for new research products.

Contact:

Ms. Connie J. Kohne, President and CEO

858-320-0097 ext. 11 or businessdevelopment@jadenbio.com